Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...

Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...

Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...

Microwave ablation (MWA) of colorectal liver metastases (CRLM) had low rates of failure and morbidity and warrants consideration as definitive treatment, authors of a large clinical review suggested.

Although the study covers a period (1997 to 2002) when the predominant chemotherapy regimen in use in the United States was the combination of fluorouracil with folinic acid, some patients in the ...

Chicago — Surgical resection is the standard of care for small colorectal liver metastases, but the results of a phase 3 trial reported at the American Society of Clinical Oncology (ASCO) 2024 annual ...

Phase Ib dose escalation and cohort expansion study of the novel myeloid differentiating agent MTL-CEBPA in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC). A ...

Thermal ablation demonstrated noninferiority to surgical resection for small colorectal liver metastases, with comparable overall survival and local control outcomes. The COLLISION trial showed ...

Treatment options for liver cancer vary based on the cancer stage and a person’s overall health and liver function. A person should work with their treatment team to determine the best treatment ...

Secondary liver cancer is cancer that has spread to the liver from another location. Treatment depends on the cancer’s origin, the amount of liver affected, and whether it has spread to other ...